We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00880932
First Posted: April 14, 2009
Last Update Posted: April 14, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Pennsylvania
  Purpose
The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.

Condition Intervention
Warfarin and NSAID Behavioral: Electronic Alert

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Official Title: The Effect of Customized Alerts Versus Generic Alerts for the Prescription of Warfarin and NSAID

Resource links provided by NLM:


Further study details as provided by University of Pennsylvania:

Primary Outcome Measures:
  • Decreased rate of prescription of the combination of warfarin and NSAID [ Time Frame: 17 months ]

Enrollment: 1865
Study Start Date: August 2006
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: customized electronic alert
This intervention was not targeted to patients with a disease but to the providers. The intervention was not a drug but a customized electronic alert, requesting the prescriber to specify a "reason for override" whenever the combination drugs of warfarin and NSAID were ordered together.
Behavioral: Electronic Alert
No Intervention: Standard practice
The control group was not patients but the providers. Providers in the control group continued with the standard practice of receiving passive alerts in the form of message boxes warning the provider not to prescribe the combination drugs warfarin and NSAID.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • All resident physicians (RP) and nurse practitioners (NP) involved in inpatient care at two hospitals of the University of Pennsylvania

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00880932


Locations
United States, Pennsylvania
Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center
Phila, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
  More Information

Responsible Party: UPenn School of Medicine
ClinicalTrials.gov Identifier: NCT00880932     History of Changes
Other Study ID Numbers: 803787
First Submitted: April 13, 2009
First Posted: April 14, 2009
Last Update Posted: April 14, 2009
Last Verified: April 2009

Keywords provided by University of Pennsylvania:
warfarin
NSAID
The condition is the concomitant prescription of

Additional relevant MeSH terms:
Warfarin
Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents